Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10484133 | Value in Health | 2014 | 9 Pages |
Abstract
Based on the Australian experience evaluating new interventions across a broad range of therapeutic areas, sensor-augmented insulin pump therapy with LGS may be considered a cost-effective alternative to standard pump therapy with self-monitoring of blood glucose in hypoglycemia unaware patients with type 1 diabetes.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Trang T. MBBS, DCH, FRACP, Alan J.M. MA Statistics, Andrew BPharm, MMedSc (clin epi), Athena BPharm, MCom, MA, MPH, Margaret E. PhD, Rudolf MSc, Timothy W. MBBS, FRACP, MD,